📖

RNA Binding Fox-1 Homolog 1 (RBFOX1)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-rbfox1

Related Entities

Metadata

slug	genes-rbfox1
entity_type	gene
kg_node_id	RBFOX1

Linked Artifacts (259)

mentions🔬What are the mechanisms underlying rna binding protein dysre75%

mentions🔬RNA binding protein dysregulation across ALS FTD AD75%

mentions🧫Microarray and single-cell RNA analysis of lipid metabolism 70%

mentions🧫dilncRNA-mediated molecular crowding and phase separation70%

mentions🧫Competing endogenous RNA (ceRNA) network construction70%

mentions🧫Factor depletion effects on DDR focus formation in vivo70%

mentions🧫Activity-dependent PGC-1α transcriptional program analysis70%

mentions🧫scRNA-seq analysis of human atherosclerotic plaques70%

mentions🧫Multi-omics analysis of NP137 mechanism in patient biopsies70%

mentions🧫Sevoflurane-induced neurotoxicity (SIN) model in rats70%

mentions🧫PGC-1α expression analysis during PV+ interneuron developmen70%

mentions🧫Multi-omics analysis of myricanol effects on gene expression70%

mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha70%

mentions🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m70%

mentions🧫LINC00599-MYH9 liquid-liquid phase separation analysis70%

mentions🧫Single-cell RNA sequencing analysis of human atherosclerotic70%

mentions🧫NPM1 knockout tumor progression study in syngeneic mice70%

mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%

mentions🧫dilncRNA-mediated molecular crowding and phase separation70%

mentions🧫Single-cell RNA-seq analysis of mouse testes with gonadal de70%

mentions🧫Gestational haloperidol exposure effects on hippocampal gene70%

mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%

mentions🧫Machine learning-based identification of C1Q hub genes70%

mentions🧫Single-cell RNA sequencing of microglial states in AD hippoc70%

mentions🧫Single-cell RNA sequencing of EMT states in SCC70%

mentions🧫BDEV injection and recipient microglial transcriptome analys70%

mentions🧫Sevoflurane-induced neurotoxicity (SIN) rat model70%

mentions🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter70%

mentions🧫Single-cell RNA sequencing analysis of microglial heterogene70%

mentions🧫Single-nucleus RNA-seq integration analysis70%

mentions🧫Small RNA profiling of neonatal astrocyte EVs and microglia 70%

mentions🧫ZNF263-mediated LINC00599 transcriptional regulation70%

mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%

mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%

mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%

mentions🧫Proposed experiment from debate on Microglia activate astroc70%

mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%

mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%

mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%

mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%

mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%

mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%

mentions🧫s:** - Compare uptake with/without magnetic particles using 70%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%

mentions🧫Proposed experiment from debate on Perivascular spaces and g70%

mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%

mentions🧫s:** - Dose-response studies showing therapeutic window with70%

mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%

mentions🧫Proposed experiment from debate on Microglia activate astroc70%

mentions🧫FLS Stimulation and Transcriptomic Analysis70%

mentions🧫Single-cell RNA sequencing of mouse brains70%

mentions🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro70%

mentions🧫LINC00599 role in human PASMC proliferation70%

mentions🧫LINC00599 expression analysis in hypoxic PH models70%

mentions🧫DDR factor depletion and focus formation analysis70%

mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%

mentions🧫AAV-LRRK2 IND-Enabling Study Design70%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%

mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%

mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%

mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk70%

mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%

mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?70%

mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap70%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

mentions🧫ApoE4 Function in Alzheimer's Disease70%

mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 70%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%

mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%

mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%

mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%

mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%

mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa70%

mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%

mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%

mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%

mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen70%

mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%

mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%

mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%

mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%

mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%

mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%

mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%

mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%

mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%

mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 70%

mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%

mentions🧫Microglial Contributions to Huntington's Disease Pathog70%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%

mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%

mentions🧫Parkinson's Disease Subtype Classification — Precision 70%

mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic70%

mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%

mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%

mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel70%

mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%

mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%

mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di70%

mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%

mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%

mentions🧫Experiment Validation: In vitro ThT Assay70%

mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%

mentions🧫Tau ASO Therapy70%

mentions🧫Microglial TREM2 Agonist In Vivo Efficacy70%

mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%

mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%

related🔬What are the mechanisms underlying rna binding protein dysre67%

related🔬RNA binding protein dysregulation across ALS FTD AD67%

related🧫Microarray and single-cell RNA analysis of lipid metabolism 63%

related🧫dilncRNA-mediated molecular crowding and phase separation63%

related🧫Competing endogenous RNA (ceRNA) network construction63%

related🧫Factor depletion effects on DDR focus formation in vivo63%

related🧫Activity-dependent PGC-1α transcriptional program analysis63%

related🧫scRNA-seq analysis of human atherosclerotic plaques63%

related🧫Multi-omics analysis of NP137 mechanism in patient biopsies63%

related🧫Sevoflurane-induced neurotoxicity (SIN) model in rats63%

related🧫PGC-1α expression analysis during PV+ interneuron developmen63%

related🧫Multi-omics analysis of myricanol effects on gene expression63%

related🧫G3BP1-mediated stress granule assembly via liquid-liquid pha63%

related🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m63%

related🧫LINC00599-MYH9 liquid-liquid phase separation analysis63%

related🧫Single-cell RNA sequencing analysis of human atherosclerotic63%

related🧫NPM1 knockout tumor progression study in syngeneic mice63%

related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%

related🧫dilncRNA-mediated molecular crowding and phase separation63%

related🧫Single-cell RNA-seq analysis of mouse testes with gonadal de63%

related🧫Gestational haloperidol exposure effects on hippocampal gene63%

related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%

related🧫Machine learning-based identification of C1Q hub genes63%

related🧫Single-cell RNA sequencing of microglial states in AD hippoc63%

related🧫Single-cell RNA sequencing of EMT states in SCC63%

related🧫BDEV injection and recipient microglial transcriptome analys63%

related🧫Sevoflurane-induced neurotoxicity (SIN) rat model63%

related🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter63%

related🧫Single-cell RNA sequencing analysis of microglial heterogene63%

related🧫Single-nucleus RNA-seq integration analysis63%

related🧫Small RNA profiling of neonatal astrocyte EVs and microglia 63%

related🧫ZNF263-mediated LINC00599 transcriptional regulation63%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%

related🧫Proposed experiment from debate on Epigenetic clocks and bio63%

related🧫Proposed experiment from debate on Microglia activate astroc63%

related🧫s:** - Test whether HCN1 knockout specifically in EC layer I63%

related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%

related🧫Proposed experiment from debate on Epigenetic clocks and bio63%

related🧫s:** - Temporal analysis showing mitochondrial defects prece63%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%

related🧫s:** - Compare uptake with/without magnetic particles using 63%

related🧫Proposed experiment from debate on Mitochondrial transfer be63%

related🧫Proposed experiment from debate on Perivascular spaces and g63%

related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%

related🧫Proposed experiment from debate on Mitochondrial transfer be63%

related🧫s:** - Dose-response studies showing therapeutic window with63%

related🧫Proposed experiment from debate on Senolytics targeting p16/63%

related🧫Proposed experiment from debate on Microglia activate astroc63%

related🧫FLS Stimulation and Transcriptomic Analysis63%

related🧫Single-cell RNA sequencing of mouse brains63%

related🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro63%

related🧫LINC00599 role in human PASMC proliferation63%

related🧫LINC00599 expression analysis in hypoxic PH models63%

related🧫DDR factor depletion and focus formation analysis63%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera63%

related🧫AAV-LRRK2 IND-Enabling Study Design63%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau63%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio63%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model63%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk63%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%

related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?63%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap63%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%

related🧫ApoE4 Function in Alzheimer's Disease63%

related🧫Autophagy Enhancement Drug Screening for Neurodegeneration63%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 63%

related🧫Blood-Based Biomarker Panel for Early AD Detection63%

related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka63%

related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study63%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%

related🧫CRISPR Gene Correction Approaches for CBS/PSP63%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa63%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 63%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%

related🧫Environmental Exposure Causal Attribution in ALS — Experimen63%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise63%

related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa63%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De63%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%

related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%

related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%

related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P63%

related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 63%

related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%

related🧫Microglial Contributions to Huntington's Disease Pathog63%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#63%

related🧫Parkinson's Disease Subtype Classification — Precision 63%

related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic63%

related🧫Progranulin Replacement Therapy for FTD — Vector Development63%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD63%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise63%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel63%

related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec63%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D63%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di63%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki63%

related🧫TDP-43 PET Ligand Development for FTD and ALS63%

related🧫Experiment Validation: In vitro ThT Assay63%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%

related🧫Tau ASO Therapy63%

related🧫Microglial TREM2 Agonist In Vivo Efficacy63%

related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia63%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 63%

see_also📖u2af260%

see_also📖Packard Center for ALS Research60%

see_also📖Neurons60%

see_also📖Neurodegeneration60%

see_also📖ANO3 Gene60%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%

mentions🧪Cryptic Exon Silencing Restoration50%

mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

mentions🧪Cross-Seeding Prevention Strategy50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬APOE4 differs from APOE3 by C112R causing domain interaction50%

related🔬RNA binding protein dysregulation across ALS FTD and AD50%

mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%

related🧪Trans-Synaptic Adhesion Molecule Modulation40%